COVID-19: Antiplatelet Agents May Reduce Thrombotic Risk ...Middle East

Medscape - News
Severe COVID-19 patients have sustained platelet activation, likely contributing to thrombotic issues seen with the infection. Antiplatelet therapy such as aspirin may be of benefit, researchers say. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( COVID-19: Antiplatelet Agents May Reduce Thrombotic Risk )

Apple Storegoogle play

Also on site :